Outsourcing

David Deere is the chief commercialization officer for PaizaBio, a US-based contract manufacturing organization and consulting group with in-country aseptic fill-and-finish operations in Hangzhou, China. Deere is a veteran global pharmaceutical executive whose career path includes Valeant Pharmaceuticals International, F. Hoffman-La Roche and Genentech.

Articles

While food, shelter, and clothing are the primal essentials for life, hope-as embodied by modern medicine-has now become part of that human expectation. 

Biosimilars and Healthcare Policy: What China Can Learn from the EU and US

The sterile-manufacturing contract development manufacturing organization is approved by FDA for viral vector manufacturing fill/finish processing at its biologics facility in Scotland, UK.

Symbiosis Secures FDA Viral Vector Process Approval

The company will showcase the evolving role of vitamins and lipid APIs in pharmaceutical applications at CPhI Worldwide 2018.

DSM to Highlight Vitamin and Lipid Portfolio at CPhI Worldwide 2018

The contract development and manufacturing organization expanded its analytical chemistry suite and added a new office in Boston, MA.

Avista Pharma Solutions Expands Service Offerings in New England

Evonik completed a EUR 36 million expansion of its contract-manufacturing capabilities for API and advanced intermediates in the United States and Germany.

Evonik Expands CMO Capabilities for APIs and Intermediates

The $425-million acquisition adds formulation development and finished dosage manufacturing capabilities to Cambrex’s existing global API manufacturing network.

Cambrex Completes Acquisition of Halo Pharma

Avara Pharmaceutical Services acquired Sandoz’s sterile manufacturing facility for injectable medicines in Boucherville, Quebec, Canada.

Avara Acquires Sterile Manufacturing Facility from Sandoz

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

More than 120 healthcare organizations plan to bring competition to generic drug market.

Hospitals Back Generic Drug Production Venture

Mark Witcher is senior consultant at Brevitas Consulting, witchermf@aol.com

Harry Silver is senior process/facility designer at Harry Silver Designs.

A multi-purpose biopharmaceutical manufacturing facility using a matrix of multi-functional cleanrooms can be adapted to efficiently meet the capacity challenges of both supplying clinical trials and launching products.

Multi-Purpose Biopharmaceutical Manufacturing Facilities Part 1:  Product Pipeline Manufacturing

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Existing software tools cannot take into account the complexity of disease.

Contract Manufacturing Services